Clinical Trial Update: Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing irradiation plus long-term androgen deprivation with a GnRH antagonist versus GnRH agonist plus flare protection in very high risk local…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)
• GnRH antagonist

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING